You've probably never thought about repurposing these items as plant holders, but many of them have more vintage charm than ...
Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS). The ...
The biggest stories of the day delivered to your inbox.